# Adult-Onset T-Cell Acute Lymphoblastic Lymphoma-Leukemia Presenting With Petechial Rash: A Case Report

**Authors:** Kelly Kimball, Vissy Elad, Edward J Hamad, Christopher Wasco

PMC · DOI: 10.7759/cureus.67744 · Cureus · 2024-08-25

## TL;DR

A 38-year-old woman with a petechial rash and abdominal bruising was diagnosed with T-ALL, highlighting the need for early recognition of this rare cancer in adults.

## Contribution

This case report emphasizes the importance of considering T-ALL in adults presenting with petechial rashes.

## Key findings

- The patient presented with a petechial rash and was diagnosed with T-ALL after biopsy.
- The patient achieved remission after four cycles of hyper-CVAD chemotherapy despite initial complications.
- The case underscores the need for early diagnosis of T-ALL in adults with non-specific symptoms.

## Abstract

T-cell acute lymphoblastic lymphoma-leukemia (T-ALL) is a rare neoplastic disease with presenting symptoms that are often non-specific. As such, accurate diagnosis requires high clinical suspicion and assessment of bone marrow aspirate with flow cytometry and morphology. While remission is achievable in most patients, the five-year survival rate is only 48% despite treatment. The standard chemotherapy regimen is referred to as hyper-CVAD, where CVAD stands for cyclophosphamide, vincristine sulfate, Adriamycin (doxorubicin), methotrexate, and dexamethasone. In this study, we describe a 38-year-old female who presented with atraumatic abdominal bruising and a petechial rash on the upper and lower extremities. Imaging revealed a 16 cm anterior mediastinal mass and a bone marrow and mediastinal mass biopsy confirmed a diagnosis of T-ALL. The patient received hyper-CVAD cycle 1A with several complications but ultimately achieved remission after four cycles. Here, we stress the importance of broadening differentials for new-onset petechial rashes in adults to include systematic lymphomas, such as T-ALL, and the need for early recognition so patients can receive timely treatment.

## Linked entities

- **Chemicals:** cyclophosphamide (PubChem CID 2907), vincristine sulfate (PubChem CID 249332), Adriamycin (PubChem CID 31703), doxorubicin (PubChem CID 31703), methotrexate (PubChem CID 4112), dexamethasone (PubChem CID 5743)
- **Diseases:** T-ALL (MONDO:0004963)

## Full-text entities

- **Diseases:** neoplastic disease (MESH:D004194), abdominal bruising (MESH:D003288), Rash (MESH:D005076), lymphomas (MESH:D008223), T-ALL (MESH:D054218)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11421832/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11421832/full.md

## References

13 references — full list in the complete paper: https://tomesphere.com/paper/PMC11421832/full.md

---
Source: https://tomesphere.com/paper/PMC11421832